A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment.
第一作者:
Mark,Allison
第一单位:
Clinical Research Department, Celerion, 2420 W. Baseline Rd., Tempe, AZ, 85283, USA. mark.allison@celerion.com.
作者:
医学主题词
投药, 鼻内(Administration, Intranasal);投药, 口服(Administration, Oral);青少年(Adolescent);成年人(Adult);生物利用度(Biological Availability);交叉研究(Cross-Over Studies);剂量效应关系, 药物(Dose-Response Relationship, Drug);多西拉敏(Doxylamine);女(雌)性(Female);组胺H1拮抗剂(Histamine H1 Antagonists);人类(Humans);男(雄)性(Male);定量雾化吸入器(Metered Dose Inhalers);中年人(Middle Aged);入睡和睡眠障碍(Sleep Initiation and Maintenance Disorders);青年人(Young Adult)
DOI
10.1007/s40268-018-0232-1
PMID
29671128
发布时间
2018-11-14
- 浏览2
Drugs in R&D
129-136页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



